References
- Miniero R., Saracco P., Einaudi S., Garofalo F., Lange M. M., Madon E. L-Asparaginase-induced coagulopathy in children with acute lymphoblastic leukemia. Drugs Exptl Clin Res 1987; 13: 377
- Homan A. C., Rybak M. E., Baglini R. L., Tiarks C., Steiner M. E., Forman E. N. Effect of L-Asparaginase administration on coagulation and platelet function in children with leukemia. J Clin Oncol 1987; 5: 811
- Legnani C., Palareti G., Pession A., Poggi M., Vecchi V., Bianchini B., Coccheri S. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen in leukemic children. Haemostasis 1988; 18: 179
- Saito M., Asakura H., Jokaji H., Uotani C., Kumabashiri I., Keiko I., Matsuda T. Changes in hemostatic and fibrinolytic proteins in patients receiving L-Asparaginase therapy. Am J Hematol 1989; 32: 20
- Vellenga E., Broekmans A. W., Kluft C. Thrombotic complications during L-Asparaginase related to protein C deficiency. Thromb Haemost 1985; 53: 443
- Cappellato M. G., Rosolen A., Zanesco L., Girolami A. Clotting complications of L-asparaginase therapy in children with ALL. Blut 1986; 52: 377
- Leone G., Gugliotta L., Mazzucconi M. G., De Stefano V., Mattioli Belmonte M., Dragoni F., Speechia G., Centra A., Gamba G., Camera A., Mandelli F. Evidence of an hyper-coagulable state in patients with acute lymphoblastic leukemia with low dose of E. Coli L-Asparaginase: A GIMEMA study, Submitted.
- Gugliotta L., D'Angelo S., Mattioli Belmonte M., Viganò D'Angelo S., Colombo G., Catoni L., Gianni L., Lauria F., Tura S. Hypercoagulability during L-Asparaginase treatment: the effect of Antitrombin III supplementation in vivo. Br J Haematol 1990; 74: 465